Other News

Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis

– Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. – Paralysis is a devastating condition for more than 5 million patients in the United States NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE)–Synchron, an endovascular brain-computer (BCI) interface company, today announced the enrollment of […]

AliveCor Launches KardiaComplete to Help Reduce the Rising Health and Economic Costs of Heart Disease

Pairs proven AI-driven remote personal monitoring solutions with easy-to-access services and virtual cardiologist visits to help improve outcomes and reduce cost of care  MOUNTAIN VIEW, Calif., May 3, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of KardiaComplete, a comprehensive heart health enterprise solution […]

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical aortic heart valve. The TRIA valve reimagines the heart valve by combining the company’s proprietary biopolymer – LifePolymer™ – with an […]

Medscape Education, American College of Cardiology Collaborate on Lipid Management and CV Risk Reduction Education

NEW YORK, May 3, 2022 /PRNewswire/ — Medscape Education and the American College of Cardiology (ACC) will collaborate in 2022 to implement an ACC-dedicated collection page on Medscape.org with two new Continuing Medical Education (CME) initiatives for lipid management and cardiovascular (CV) risk reduction. This collaboration will combine ACC and Medscape’s strengths in learning […]

Lark Health Adds Former Evernorth and Salesforce Executives to Leadership Team

Dr. Lynne Nowak Joins Lark as Chief Medical Officer and Shannon Marques Joins as Senior Vice President of Revenue Operations MOUNTAIN VIEW, Calif., May 3, 2022 /PRNewswire/ — Lark Health today announced it has appointed Lynne Nowak, MD, as Chief Medical Officer and Shannon Marques as Senior Vice President of Revenue Operations. Dr. Nowak and Marques are […]

UltraSight Announces Appointment of Dr. Ruth Atherton, JD to Board of Directors

Expansion of board signals digital health company’s growth and increased focus on creating access to cardiac ultrasound TEL AVIV, Israel, May 3, 2022 /PRNewswire/ — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, is proud to announce that Ruth Atherton, PhD, JD, has joined its board of […]

Semler Reports First Quarter 2022 Financial Results

2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million, an increase of $0.8 million, or 6%, compared to $13.2 million Net income was $3.4 million, or $0.50 per basic share and $0.41 per diluted share, compared to $4.9 million, or $0.73 per basic share and $0.60 per diluted share Cash at March 31, 2022 increased to $38.4 million from $26.5 million SANTA CLARA, Calif., May […]

STAR Network to Collaborate with Avail Surgical Telepresence Platform to Enhance Collaboration Among Physicians

With the Avail Platform, Collaborators participating in STAR — the Stroke Thrombectomy and Aneurysm Registry — Can Lean on each other and Work Together, Regardless of Location or Hour SANTA CLARA, Calif., May 3, 2022 /PRNewswire/ — Avail Medsystems, a healthcare technology company whose surgical telepresence platform facilitates real-time, interactive collaboration during live procedures among […]

New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)

The latest prespecified and post hoc sub-analysis of the landmark REDUCE-IT® study, published today in the Journal of the American College of Cardiology (JACC), demonstrated that VASCEPA® (icosapent ethyl) significantly reduces the total ischemic event risk of cardiovascular death, stroke, myocardial infarction (heart attack), coronary revascularization, or hospitalization for unstable angina by 35% […]